–
Rani Therapeutics Holdings, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−51.6
FY22:
−63.5
FY23:
−66.1
FY24:
−53.3
FY25:
−38.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−51.0
FY22:
−61.7
FY23:
−62.0
FY24:
–
FY25:
−36.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−53.0
FY22:
−63.3
FY23:
−67.9
FY24:
–
FY25:
−41.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−8.33
FY22:
−30.6
FY23:
−34.0
FY24:
−30.0
FY25:
−29.7
All amounts in millions USD